G Medical Innovations Holdings Ltd
GMVDF
$0.00
$0.000.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 1.10M | 1.10M | 1.11M | 1.11M | 1.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.10M | 1.10M | 1.11M | 1.11M | 1.02M |
| Cost of Revenue | -1.75M | -1.75M | 3.57M | 3.57M | 834.00K |
| Gross Profit | 2.85M | 2.85M | -2.46M | -2.46M | 184.00K |
| SG&A Expenses | 5.61M | 5.61M | 7.34M | 7.34M | 3.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.41M | 4.41M | 11.51M | 11.51M | 4.37M |
| Operating Income | -3.31M | -3.31M | -10.39M | -10.39M | -3.35M |
| Income Before Tax | -334.00K | -334.00K | -6.64M | -6.64M | -4.91M |
| Income Tax Expenses | 1.50K | 1.50K | 6.50K | 6.50K | 1.00K |
| Earnings from Continuing Operations | -335.50K | -335.50K | -6.64M | -6.64M | -4.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 85.50K | 85.50K | 133.00K | 133.00K | 26.50K |
| Net Income | -250.00K | -250.00K | -6.51M | -6.51M | -4.88M |
| EBIT | -3.31M | -3.31M | -10.39M | -10.39M | -3.35M |
| EBITDA | -3.24M | -3.24M | -10.09M | -10.09M | -3.17M |
| EPS Basic | -0.27 | -0.27 | -12.66 | -12.66 | -12.67 |
| Normalized Basic EPS | -0.13 | -0.13 | -7.80 | -7.80 | -7.89 |
| EPS Diluted | -0.27 | -0.27 | -12.66 | -12.66 | -12.67 |
| Normalized Diluted EPS | -0.13 | -0.13 | -7.80 | -7.80 | -7.89 |
| Average Basic Shares Outstanding | 927.30K | 927.30K | 514.50K | 514.50K | 385.40K |
| Average Diluted Shares Outstanding | 927.30K | 927.30K | 514.50K | 514.50K | 385.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |